Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on May 20, 2025

Ensemble and Solventum Partner to Advance Autonomous Inpatient Coding with AI
CINCINNATI, Ohio and ST. PAUL, Minn., May 20, 2025 (GLOBE NEWSWIRE) -- Ensemble, an industry leading revenue cycle management company, announced a strategic partnership today with Solventum, a market leader and innovator in AI-driven revenue cycle …

Mullen Announces Quarterly Results for 3 Months Ended March 31, 2025
Company fiscal Q2 outperforms all previous quarterly revenue results Mullen achieves strong results with $5M revenue for quarter ending March 31, 2025 Company revenue is $7.9M for six months ended March 31, 2025 Company net loss decreased substantially …

Encuesta sobre el estado de pequeñas empresas 2025: Crece la demanda de IA, ciberseguridad y redes sociales
Los datos de Verizon Business revelan que las pequeñas empresas están ampliando sus habilidades tecnológicas y utilizando la IA para todo, desde estrategias de redes sociales hasta reclutamiento laboral Lo que debes saber: Casi la mitad (47%) de las …

2025 State of Small Business Survey: Surge in AI, cybersecurity and social media demand
Verizon Business data reveals SMBs expanding tech skills and leveraging AI for everything from social media strategies to workplace hiring What you need to know: Nearly half (47%) of SMBs updated their cybersecurity solutions to further protect their …

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts
Vancouver, Canada, May 20, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve …

Johnson Fistel Investigates Fairness of Proposed Sale of TXNM Energy, Inc.
SAN DIEGO, May 20, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP has launched an investigation into whether the board members of TXNM Energy, Inc. (NYSE: TXNM) breached their fiduciary duties in connection with the proposed sale of the Company to …

Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being ‘Ms. Represented’ in First-of-its-Kind Campaign with Supernus Pharmaceuticals
Females with ADHD frequently present with inattentive symptoms, which can be more difficult to recognize than the hyperactive and impulsive symptoms more often seen in males Boys are two times more likely to be diagnosed with ADHD than girls, leaving many …

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake
SEATTLE and VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

Freight Technologies Announces First Quarter 2025 Results
HOUSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT; “Fr8Tech” or the “Company”), a logistics management innovation company, offering a diverse portfolio of technology-driven solutions, released its results for the first …

KOIL Energy Reports First Quarter 2025 Results
HOUSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Koil Energy Solutions, Inc. (OTCQB: KLNG), a specialist in deepwater energy production and distribution equipment and services, released today its first quarter 2025 results. First Quarter 2025 Results Revenue of $ …

Stonehill Wins Gold TITAN Business Award Professional Services Category
Stonehill is proud to announce that it has been honored with the Gold TITAN Business Award within the Company …

Mersana Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, …

Reflect Scientific Receives Over $250,000 in New Orders for High-Performance Freezers from International Biotech and Pharma Clients
OREM, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of advanced cryogenic and refrigeration technologies, announced today it has received over $250,000 in new orders for its high-performance freezer systems. The …

Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

Enlivex Selected to Present at Israeli BioMed 2025 Conference
Presentation to highlight Allocetra™ and the therapeutic potential of macrophage reprogramming in inflammatory diseases Ness-Ziona, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage …

SELLAS Life Sciences to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …

PDS Biotech to Participate at the A.G.P. Virtual Annual Healthcare Company Showcase
PRINCETON, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …

Aventis Energy Provides Recent Exploration Insights at the Corvo Uranium Project
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Aventis Energy. (“Aventis” or the “Company”) (CSE: AVE | OTC: VBAMF), is pleased to provide a comprehensive summary of exploration insights and historical data gathered at its Corvo Uranium …

ALX Oncology Highlights Differentiated Design, Preclinical Data and Development Plans for EGFR-Targeted ADC, ALX2004, in R&D Webcast Event
- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed with every component optimized to maximize the therapeutic window by reducing toxicity - Following recent …

Praxis Precision Medicines to Participate in Upcoming Conferences
BOSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …